Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Kristen R Spencer
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
180 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- the Angeles Clinic and Research Institute - West Los Angeles Office
Los Angeles, California, United States
- Va Palo Alto Health Care System
Palo Alto, California, United States
- Um Sylvester Comprehensive Cancer Center at Aventura
Aventura, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Coral Gables
Coral Gables, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Coral Springs
Coral Springs, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Deerfield Beach
Deerfield Beach, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Hollywood
Hollywood, Florida, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Kendall
Miami, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Plantation
Plantation, Florida, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
- Saint Luke'S Cancer Institute - Fruitland
Fruitland, Idaho, United States
- Saint Luke'S Cancer Institute - Meridian
Meridian, Idaho, United States
- Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
- Saint Luke'S Cancer Institute - Nampa
Nampa, Idaho, United States
- Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, United States
- Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho, United States
- Advocate Good Shepherd Hospital
Barrington, Illinois, United States
- Advocate Illinois Masonic Medical Center
Chicago, Illinois, United States
- John H Stroger Jr Hospital of Cook County
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Amg Crystal Lake - Oncology
Crystal Lake, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Advocate Good Samaritan Hospital
Downers Grove, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Advocate Sherman Hospital
Elgin, Illinois, United States
- Advocate South Suburban Hospital
Hazel Crest, Illinois, United States
- Amg Libertyville - Oncology
Libertyville, Illinois, United States
- Condell Memorial Hospital
Libertyville, Illinois, United States
- Carle Physician Group-Mattoon/charleston
Mattoon, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2024
- Primary completion
- 31 Dec 2028
- Completion
- 31 Dec 2028
- Last update posted
- 22 Oct 2026
- Registered enrollment
- 105
- Registry id
- NCT05638295
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.